Retrolental Fibroplasia
📋Overview
Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Retrolental Fibroplasia is a condition that typically develops in infants who are born prematurely.
Gestational Age and Birth Weight
Infants born before 31 weeks of gestation are considered at a higher risk for developing this condition.
Very low birth weight is another significant factor, as infants weighing less than 1,250 grams are more frequently affected.
Vulnerable Populations
The condition is most commonly observed in neonatal intensive care units where highly premature babies receive specialized support.
- •Stage 1 involves mildly abnormal blood vessel growth at the junction of the vascularized and non-vascularized retina.
- •Stage 2 is characterized by a ridge of moderately abnormal blood vessel growth.
- •Stage 3 involves severely abnormal blood vessel growth extending into the vitreous.
- •Stage 4 represents a partial retinal detachment where the retina begins to pull away from the back of the eye.
- •Stage 5 is the most severe variant, involving a complete retinal detachment.
- •Plus disease is a variant where retinal vessels become significantly enlarged and twisted.
- •Aggressive posterior ROP is a rapidly progressing form that requires urgent clinical attention.
- •Threshold ROP is a clinical classification indicating the disease has reached a severity where treatment is typically recommended.
- •Abnormal growth of blood vessels within the retina
- •Development of scar tissue on the retinal surface
- •Partial or complete retinal detachment in advanced stages
- •Appearance of a white pupil, also known as leukocoria
- •Involuntary or abnormal eye movements, such as nystagmus
- •Misalignment of the eyes, commonly referred to as strabismus
- •Severe nearsightedness or myopia
- •Significant visual impairment or total blindness in severe cases
- •Premature birth, particularly in infants born before 31 weeks of gestation.
- •Very low birth weight, often involving infants weighing less than 3 pounds.
- •Exposure to high concentrations of supplemental oxygen therapy.
- •Respiratory distress syndrome or the requirement for mechanical ventilation.
- •Presence of neonatal sepsis or other systemic infections.
- •Occurrence of intraventricular hemorrhage or bleeding in the brain.
- •Anemia or the necessity for multiple blood transfusions.
- •Concurrent medical complications such as congenital heart disease.
The progression of Retrolental Fibroplasia is typically observed in the first few weeks following a premature birth. The clinical course is characterized by the abnormal development of retinal blood vessels, which can follow divergent paths based on the severity of the initial presentation.
Spontaneous Regression
In many mild cases, the condition may resolve without medical intervention. During this period, the abnormal vascular growth ceases, and the retinal vessels may continue to develop in a more typical pattern, reducing the risk of long-term impairment.
Disease Progression
If the condition continues to advance, it can lead to the formation of fibrous scar tissue. This progression may eventually cause the retina to pull away from the inner wall of the eye, a process that can result in permanent visual impairment or total vision loss if not managed promptly.
Retrolental Fibroplasia is diagnosed through a detailed retinal examination. An ophthalmologist examines the inside of the eye to check for signs of abnormal blood vessel growth and to determine the stage of the condition.
Screening Criteria
Medical professionals typically perform eye exams on infants born before 30 weeks of gestation or those weighing less than 3 pounds (1,500 grams). Infants considered to be at high risk for other clinical reasons may also undergo evaluation.
Timing of Exams
The initial examination is generally conducted between 4 and 9 weeks after birth. Infants born at 27 weeks or later are usually tested when they are 4 weeks old, while those born earlier may be tested at a later date depending on their development.
Management of Retrolental Fibroplasia primarily involves regular screening of at-risk infants to identify abnormal vessel development at an early stage. The primary goal of clinical intervention is to prevent the progression of the condition and minimize the risk of permanent vision loss.
Therapeutic Interventions
Treatment strategies are designed to stop the growth of abnormal blood vessels in the retina. Clinical options may include laser therapy or cryotherapy to target the peripheral retina, which can help prevent retinal detachment.
In more advanced cases, surgical procedures such as vitrectomy or scleral buckling may be considered to address complications like retinal scarring or detachment. The choice of treatment depends on the severity and stage of the condition observed during ophthalmologic examinations.
While surgical interventions are often the primary focus of treatment, pharmacological agents play a critical role in managing the vascular growth patterns characteristic of the condition. These medications are typically administered directly to the vitreous to target the underlying causes of neovascularization.
Anti-VEGF Medications
Intravitreal injections of anti-vascular endothelial growth factor agents are used to suppress the overproduction of proteins that stimulate abnormal vessel growth. This approach helps to stabilize the retina and prevent detachment.
Topical Agents
Mydriatic and cycloplegic agents are used to dilate the pupil for comprehensive retinal screening. Topical anesthetics are also utilized to facilitate examinations and minimize distress during clinical procedures.
Retrolental Fibroplasia is a legacy term describing a condition now universally classified as Retinopathy of Prematurity (ROP). Safety considerations primarily focus on the management of risk factors in neonatal care, particularly regarding the administration of supplemental oxygen to premature infants with developing retinal blood vessels.
Oxygen Therapy Considerations
Excessive arterial oxygen levels have been identified as a significant contributing factor to the development of this condition. Clinical teams typically utilize continuous pulse oximetry to monitor oxygen saturation levels, aiming to maintain levels within specific target ranges that support organ function while minimizing potential retinal toxicity.
Screening and Monitoring
Infants born prematurely or with very low birth weights are generally screened for signs of abnormal blood vessel growth in the retina. Early detection through dilated eye examinations allows for timely intervention if the condition progresses to a stage requiring treatment, such as laser therapy or cryotherapy, to prevent potential retinal detachment.
The primary approach to managing Retrolental Fibroplasia involves close monitoring of retinal blood vessel development and the application of medical treatments such as laser therapy or cryotherapy. Because this condition occurs in premature infants, any adjunctive care is managed as part of a comprehensive neonatal intensive care plan.
Clinical Care Integration
Nutritional support in a clinical setting is aimed at promoting the overall health and growth of the premature infant. While specific supplements are not a standard primary treatment for abnormal retinal vascularization, the medical team ensures that the infant receives the necessary nutrients to support systemic development.
Medical Supervision
It is essential that all interventions, including any potential nutritional adjuncts, are directed by the treating physician. Neonatal care requires precise control over all substances administered to the infant to avoid complications and to support the effectiveness of primary medical treatments.
Retrolental Fibroplasia is a legacy designation for the condition now clinically standardized as Retinopathy of Prematurity (ROP). This disorder involves the disorganized growth of blood vessels in the retina and primarily affects infants born prematurely. Historical medical evidence identified a strong correlation between the development of this condition and the administration of high levels of oxygen, which was once common in neonatal incubators before the risks were fully understood.
Oxygen Therapy and Safety Monitoring
In earlier medical practice, the unrestricted use of oxygen to treat respiratory distress in premature babies was a primary driver of the condition. Current clinical guidelines emphasize the precise regulation of oxygen saturation. Medical teams must balance the infant's need for oxygen to support vital organ function against the potential toxicity that stimulates abnormal vascular growth in the eye. While modern monitoring techniques have improved safety, the condition remains a consideration for infants requiring significant respiratory support.
Risk Factors and Clinical Complications
Evidence indicates that the risk of developing this condition increases with lower birth weights (typically under 1,500 grams) and earlier gestational ages (usually before 31 weeks). Additional factors that may contribute to the severity of the condition include anemia, the need for blood transfusions, and overall poor health status. If the condition progresses, it can lead to severe complications such as retinal detachment, glaucoma, strabismus (crossed eyes), and permanent blindness.
Early intervention is critical for managing Retrolental Fibroplasia to prevent the progression of abnormal blood vessel growth and potential retinal detachment. Clinical teams prioritize stabilizing the infant's environment while monitoring the vascularization of the retina.
Surgical and Procedural Interventions
Laser therapy, also known as photocoagulation, may be utilized to target the peripheral retina. This procedure can help stop the growth of abnormal vessels and reduce the risk of scarring.
Cryotherapy is another procedural option where clinicians use freezing temperatures to treat specific areas of the retina. This approach aims to achieve similar outcomes to laser treatment in preventing further complications.
Management of Advanced Complications
In cases where the condition progresses to retinal detachment, surgical procedures such as scleral buckling or a vitrectomy may be necessary. These interventions are designed to repair the eye and preserve remaining vision.
Ongoing clinical observation by pediatric ophthalmologists is essential to monitor the infant's progress. Regular follow-up care allows for the timely identification of changes that might require additional specialized care.
Ongoing clinical surveillance is necessary for individuals diagnosed with Retrolental Fibroplasia to manage the evolving nature of the condition throughout childhood and into adulthood.
Monitoring for Late Complications
Regular ophthalmic examinations are essential to detect and manage secondary issues that can arise after the initial acute phase. These follow-up visits allow clinicians to monitor for retinal detachment, which can occur later in life.
Healthcare providers also track the development of strabismus, or misaligned eyes, and refractive errors such as severe nearsightedness. Early identification of these conditions is critical for maintaining the best possible visual function.
Supportive Care and Rehabilitation
Visual rehabilitation programs may be recommended to help children maximize their remaining sight and adapt to any permanent vision loss. These programs often involve specialized tools and techniques tailored to the individual's specific needs.
Supportive therapies and educational planning can assist in navigating school environments. Coordinating care between ophthalmologists, pediatricians, and educators ensures that appropriate accommodations are in place to support long-term development.
- •Severe nearsightedness (myopia) may develop.
- •Strabismus (crossed eyes) can occur.
- •Amblyopia (lazy eye) is a potential complication.
- •Retinal detachment may happen in severe cases.
- •Permanent vision loss or blindness can result.
Individuals affected by Retrolental Fibroplasia often benefit from ongoing clinical monitoring and tailored support systems to address varying degrees of vision impairment.
Educational and Developmental Support
Children experiencing vision loss may require specialized educational programs designed to accommodate their specific visual needs. These programs often include the use of low-vision aids and adaptive technologies to facilitate learning and participation in classroom activities.
Early intervention services can play a significant role in optimizing developmental milestones. A multidisciplinary team, including ophthalmologists, pediatricians, and vision specialists, typically collaborates to create a comprehensive care plan focused on maximizing independence.
Long-Term Management and Adaptation
Regular follow-up appointments are essential for monitoring eye health and adjusting interventions as the individual grows. Maintaining a consistent schedule with eye care professionals helps in identifying any secondary complications that might arise over time.
Individuals living with Retrolental Fibroplasia often require specific environmental modifications to navigate daily activities safely and effectively. These strategies are designed to maximize functional vision and support developmental progress.
Environmental and Visual Adaptations
Enhancing the physical environment through high-contrast materials and specialized lighting can improve spatial awareness for those with visual impairment. These adjustments help reduce the risk of accidents and facilitate easier navigation of living spaces.
The integration of assistive technologies and educational tools may be necessary to support communication and learning. These resources are typically customized based on the severity of vision loss and the specific needs of the individual.
Clinical Monitoring and Safety
Regular ophthalmological examinations are critical for monitoring secondary conditions such as severe myopia or the risk of retinal detachment. Consistent screening allows for timely adjustments to corrective lenses or other necessary interventions.
Participation in early intervention programs can help address developmental milestones that may be impacted by visual limitations. These programs often involve coordination between healthcare providers and educational specialists to ensure a supportive environment.
Reducing the risk of Retrolental Fibroplasia requires a multi-faceted approach centered on the physiological needs of premature infants. Clinical strategies focus on maintaining stable internal environments to prevent the abnormal vascular development associated with this condition.
Oxygen Management and Monitoring
The regulation of supplemental oxygen therapy is a critical component of risk reduction. Medical teams closely monitor arterial oxygen levels to ensure that infants receive sufficient oxygen for organ function while avoiding excessive concentrations that can trigger oxidative stress in the developing retina.
Advanced monitoring technologies in neonatal intensive care units allow for real-time adjustments to oxygen delivery. Maintaining these levels within a specific clinical range may help minimize the potential for vascular damage.
Clinical Screening and Neonatal Care
Timely ophthalmic screening for infants born prematurely or at a low birth weight is essential for early detection. Regular examinations by a pediatric ophthalmologist allow for the identification of early vascular changes, which can prevent the progression to more severe stages of the disorder.
Optimizing general neonatal intensive care practices also contributes to improved outcomes. Comprehensive care that addresses the overall health and stability of the infant can reduce the physiological stressors that often contribute to the development of retinal complications.
🟢 Routine or Self-Care Situations
Routine care for this condition involves attending all scheduled ophthalmic screenings as recommended by the neonatal care team to monitor the progression of retinal blood vessel growth. These examinations are standard for infants born prematurely or at low birth weights and are typically managed through regular follow-up appointments with a pediatric ophthalmologist to ensure normal ocular development.
🟡 When to Contact a Healthcare Professional
A healthcare provider should be contacted if an infant demonstrates unusual visual behaviors, such as a persistent lack of tracking or an inability to focus on faces and objects during developmental milestones. Clinical consultation is also advised if a white reflection is observed in the pupil, known as leukocoria, or if the eyes appear consistently misaligned or cross-eyed beyond the initial months of life.
🔴 Emergency Warning Signs
Prompt medical evaluation is necessary if there is a sudden and noticeable change in the infant's eye appearance, such as acute redness, significant swelling, or a rapid loss of visual responsiveness. While most cases are managed through ongoing surveillance, any signs of acute ocular distress or sudden changes in eye movement should be evaluated by a medical professional to rule out advanced complications.
Management of Retrolental Fibroplasia requires a multidisciplinary approach involving specialized medical facilities and educational resources for families. Because this condition primarily affects premature infants, care is typically initiated within intensive clinical settings before transitioning to long-term ophthalmic monitoring.
Specialized Clinical Settings
Infants at risk for this condition are often monitored in Level III or Level IV Neonatal Intensive Care Units (NICUs). These facilities possess the specialized equipment and neonatal staff necessary to manage oxygen levels and monitor vascular development in the retina.
Pediatric ophthalmology clinics and specialized eye institutes provide the necessary diagnostic imaging and surgical interventions if abnormal vessel growth progresses. Ongoing follow-up care with a pediatric ophthalmologist is a standard component of the long-term management plan.
Educational and Support Resources
National health organizations and government agencies provide clinical information and support for families navigating a diagnosis. These resources offer guidance on understanding the progression of retinal vascular disorders and the importance of timely screenings.
- •Retinal detachment resulting from abnormal vessel scarring.
- •Myopia, or severe nearsightedness, appearing later in life.
- •Strabismus, characterized by improper eye alignment.
- •Amblyopia, which may impair visual acuity in one or both eyes.
- •Glaucoma, involving potential damage to the optic nerve.
- •Bronchopulmonary dysplasia, a chronic lung disease.
- •Cataracts, which can cause clouding of the eye's lens.
- •Nystagmus, involving involuntary rapid eye movements.
- •Learning disabilities or developmental delays.
- •Hearing loss or auditory processing issues.
Outcomes for infants with Retrolental Fibroplasia are heavily influenced by early detection and the specific grade of the disease. When identified and managed promptly, the potential for severe vision loss is often reduced.
Disease Severity and Resolution
In many instances involving mild disease (Grade 1 or 2), the condition may improve without the need for surgical treatment. However, more advanced stages present a significant risk to visual development. If the disease progresses unchecked, it can lead to retinal detachment and permanent blindness.
Long-Term Ocular Health
Infants diagnosed with this condition may remain at risk for other eye problems as they grow, even if the initial disease resolves. Clinical evidence indicates a higher likelihood of developing secondary complications later in life, including nearsightedness (myopia), crossed eyes (strabismus), lazy eye (amblyopia), and glaucoma.
Additional Resources
Trusted U.S. support resources that may be relevant to Retrolental Fibroplasia:
For emergencies, call 911. For crisis support, call or text 988.
Images can provide general visual context for Retrolental Fibroplasia, but appearance alone is not used to diagnose medical conditions. Symptoms, medical history, and clinical evaluation are more important.
View visual references (external)Overall Community Experience
No experiences shared yet — be the first to share your experience.
Shared experiences are personal and do not replace medical advice.
Share Your Experience with Retrolental Fibroplasia
Answer each question one at a time. Your full experience is submitted only after the last question. Responses are anonymous.
Overall Impact on Daily Life
How much did this condition affect your daily life? (Work, school, sleep, social life, daily activities)
No impact → Completely disruptive
One question at a time · submitted at the end
Medical codes (for reference)
UMLS CUI: C0035344Codes are provided for reference and interoperability. They are not a diagnosis.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.